Building on this success, we directed ABE-Umax to install SNVs in four genes implicated in neurodevelopmental disorders (eprs1, spata5l1, cog1, and adam22), and achieved 100%; 100%; 95%; and 90% editing, respectively (Supplementary Fig. 14). The gene discussed is EPRS1; the disease is neurodevelopmental disorder.